Firefly Neuroscience, Stock Performance
| AIFF Stock | 3.25 0.02 0.62% |
The firm shows a Beta (market volatility) of -0.37, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Firefly Neuroscience, are expected to decrease at a much lower rate. During the bear market, Firefly Neuroscience, is likely to outperform the market. At this point, Firefly Neuroscience, has a negative expected return of -0.97%. Please make sure to confirm Firefly Neuroscience,'s value at risk, rate of daily change, relative strength index, as well as the relationship between the kurtosis and market facilitation index , to decide if Firefly Neuroscience, performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Firefly Neuroscience, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Actual Historical Performance (%)
One Day Return 0.62 | Five Day Return 8.33 | Year To Date Return (34.74) | Ten Year Return (32.29) | All Time Return (77.06) |
Last Split Factor 1:3 | Last Split Date 2024-08-13 |
1 | Firefly Neuroscience expands board, appoints new directors - Investing.com | 08/20/2024 |
2 | Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwrights 26th Annual Global Investment Conference September 9-11 | 08/26/2024 |
3 | Firefly Neuroscience to Participate in Upcoming October Investor Conferences | 10/11/2024 |
4 | Acquisition by David Johnson of 557885 shares of Firefly Neuroscience, subject to Rule 16b-3 | 10/22/2024 |
5 | Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event | 11/06/2024 |
| Begin Period Cash Flow | 653 K |
Firefly |
Firefly Neuroscience, Relative Risk vs. Return Landscape
If you would invest 844.00 in Firefly Neuroscience, on August 13, 2024 and sell it today you would lose (519.00) from holding Firefly Neuroscience, or give up 61.49% of portfolio value over 90 days. Firefly Neuroscience, is currently does not generate positive expected returns and assumes 10.2968% risk (volatility on return distribution) over the 90 days horizon. In different words, 91% of stocks are less volatile than Firefly, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Firefly Neuroscience, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Firefly Neuroscience,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Firefly Neuroscience,, and traders can use it to determine the average amount a Firefly Neuroscience,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0943
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AIFF |
Estimated Market Risk
| 10.3 actual daily | 91 91% of assets are less volatile |
Expected Return
| -0.97 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Firefly Neuroscience, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Firefly Neuroscience, by adding Firefly Neuroscience, to a well-diversified portfolio.
Firefly Neuroscience, Fundamentals Growth
Firefly Stock prices reflect investors' perceptions of the future prospects and financial health of Firefly Neuroscience,, and Firefly Neuroscience, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Firefly Stock performance.
| Operating Margin | (125.90) % | ||||
| Current Valuation | 27.19 M | ||||
| Shares Outstanding | 7.34 M | ||||
| Price To Book | 19.64 X | ||||
| Price To Sales | 423.28 X | ||||
| EBITDA | (4.55 M) | ||||
| Net Income | (3.79 M) | ||||
| Total Debt | 2.25 M | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (2.89 M) | ||||
| Earnings Per Share | (0.30) X | ||||
| Total Asset | 135 K | ||||
| Retained Earnings | (73.91 M) | ||||
About Firefly Neuroscience, Performance
By analyzing Firefly Neuroscience,'s fundamental ratios, stakeholders can gain valuable insights into Firefly Neuroscience,'s financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Firefly Neuroscience, has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Firefly Neuroscience, has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Firefly Neuroscience, is entity of United States. It is traded as Stock on NASDAQ exchange.Things to note about Firefly Neuroscience, performance evaluation
Checking the ongoing alerts about Firefly Neuroscience, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Firefly Neuroscience, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Firefly Neuroscience, generated a negative expected return over the last 90 days | |
| Firefly Neuroscience, has high historical volatility and very poor performance | |
| Firefly Neuroscience, has high likelihood to experience some financial distress in the next 2 years | |
| Firefly Neuroscience, was previously known as Wavedancer and was traded on NASDAQ Exchange under the symbol WAVD. | |
| Net Loss for the year was (3.79 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Firefly Neuroscience, generates negative cash flow from operations | |
| Firefly Neuroscience, has a frail financial position based on the latest SEC disclosures | |
| About 45.0% of the company shares are held by company insiders | |
| Latest headline from globenewswire.com: Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event |
- Analyzing Firefly Neuroscience,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Firefly Neuroscience,'s stock is overvalued or undervalued compared to its peers.
- Examining Firefly Neuroscience,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Firefly Neuroscience,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of Firefly Neuroscience,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Firefly Neuroscience,'s stock. These opinions can provide insight into Firefly Neuroscience,'s potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Firefly Stock analysis
When running Firefly Neuroscience,'s price analysis, check to measure Firefly Neuroscience,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Firefly Neuroscience, is operating at the current time. Most of Firefly Neuroscience,'s value examination focuses on studying past and present price action to predict the probability of Firefly Neuroscience,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Firefly Neuroscience,'s price. Additionally, you may evaluate how the addition of Firefly Neuroscience, to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |